0.6999
4.52%
-0.0331
Dopo l'orario di chiusura:
.70
0.000100
+0.01%
Precedente Chiudi:
$0.733
Aprire:
$0.718
Volume 24 ore:
801.55K
Relative Volume:
0.26
Capitalizzazione di mercato:
$9.77M
Reddito:
$294.20K
Utile/perdita netta:
$-12.25M
Rapporto P/E:
-0.1386
EPS:
-5.05
Flusso di cassa netto:
$-10.77M
1 W Prestazione:
+10.48%
1M Prestazione:
-18.62%
6M Prestazione:
+106.40%
1 anno Prestazione:
-61.54%
Aethlon Medical Inc Stock (AEMD) Company Profile
Nome
Aethlon Medical Inc
Settore
Industria
Telefono
619-941-0360
Indirizzo
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Confronta AEMD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.6999 | 9.77M | 294.20K | -12.25M | -10.77M | -5.05 |
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Aethlon Medical Inc Borsa (AEMD) Ultime notizie
Aethlon Medical (NASDAQ:AEMD) Earns Buy Rating from HC Wainwright - Defense World
Aethlon Medical treats first subject with Hemopurifier device in Australia - Medical Device Network
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Cancer Clinical Trial update - Investorideas.com newswire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient in Australian Hemopurifier® Cancer Trial - Investorideas.com newswire
Aethlon announces treatment of first patient with Hemopurifier in Australia - TipRanks
Revolutionary Blood Filter Could Boost Cancer Immunotherapy Success Rates by 60% - StockTitan
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December - Defense World
Biostage (OTCMKTS:BSTG) and Aethlon Medical (NASDAQ:AEMD) Head to Head Review - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Head-To-Head Survey: Aethlon Medical (NASDAQ:AEMD) & West Pharmaceutical Services (NYSE:WST) - Defense World
Aethlon Medical receives extension to meet Nasdaq listing requirements - Investing.com
Aethlon Medical receives extension to meet Nasdaq listing requirements By Investing.com - Investing.com UK
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PR Newswire
Aethlon Medical provides update on availability of Hemopurifier device - TipRanks
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Head-To-Head Analysis: AtriCure (NASDAQ:ATRC) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - GlobeNewswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November - Defense World
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Maxim retains hold on Aethlon Medical shares amid clinical progress By Investing.com - Investing.com UK
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Medical Device Network
Aethlon Medical Launches Breakthrough Cancer Trial for Hemopurifier® Treatment | AEMD Stock News - StockTitan
Aethlon Medical (AEMD) Sets Q2 2024 Earnings Release for November 13 | AEMD Stock News - StockTitan
Finansavisen - Finansavisen
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now - The Manila Times
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Is Aethlon Medical Inc (AEMD) worth investing in despite its overvalued state? - US Post News
Daily Progress: Aethlon Medical Inc (AEMD) Gain 1.15, Closing at 0.40 - The Dwinnex
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... - Yahoo Finance
Aethlon Medical Inc Azioni (AEMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):